Loading...
OTC Markets
Totals
Securities
12,292
Dollar Vol
$3.2B
Share Vol
3.5B
Trades
420,973

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

Purepoint Uranium Group Inc. Company Logo

PTUUF
Purepoint Uranium Group Inc.

Ordinary Shares

0.4981

0.0121

2.49%

0.494 / 0.5119 (27500 x 5000)

Real-Time Best Bid & Ask: 05:00pm 10/09/2025
Delayed (15 Min) Trade Data: 03:47pm 10/09/2025

Purepoint Uranium Group Inc.

120 Adelaide St. West

Suite 2500

Toronto, ON M5H 1T1

Canada

Principal Executive Offices:

120 Adelaide St. West

Suite 2500

Toronto, ONT M5H 1T1

Canada

Business Description
Purepoint Uranium Group Inc. is a focused explorer with a dynamic portfolio of advanced projects within the renowned Athabasca Basin in Canada. The most prospective projects are actively operated on behalf of partnerships with industry leaders including Cameco Corporation, Orano Canada Inc. and IsoEnergy Ltd. Additionally, the Company holds a promising VHMS project currently optioned to and strategically positioned adjacent to and on trend with Foran Corporation's McIlvena Bay project. Through a robust and proactive exploration strategy, Purepoint is solidifying its position as a leading explorer in one of the globe's most significant uranium districts.
Financial Reporting
Reporting Status
International Reporting: TSX Venture Exchange
Audited Financials
Audited
CIK
0001860710
Fiscal Year End
12/31
Company Officers & Contacts
Christopher Frostad
CEO, President

Coimbatore Ramachandran
CFO

Scott Frostad
VP Expl.

Jhorose Cardenas
Director, Fin.

Board of Directors
Allan Beach
Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member

Borys Chabursky
Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member

Mr. Chabursky is the founder and Chairman of Shift Health as well as Chairman of boutique investment bank SHI Capital and President of SHI Ventures, an angel investment company. He was named one of Canada's "Top 40 Under 40" for outstanding contributions to the health industry.

Christopher Frostad
CEO, President

Scott Frostad

Other Company Insiders

None

Other Company Insiders are all persons or entities beneficially owning 10% or more of any class of the issuer's securities. Together, officers, directors and other company insiders comprise Company Insiders.
Service Providers
Accounting/Auditing Firm
MNP LLP

50 Burnhamthorpe Road West,

Suite 900

Mississauga, ON L5B 3C2

Canada

Securities Counsel
Kuo Securities Law Professional Corporation

Suite 635, Bay Adelaide Centre

33 Bay Sreet

Toronto, ON M5H 2R2

Canada

Profile Data
Joined OTCQB
08/2021
SIC - Industry Classification
Not Available
Incorporation Information
ON, CA, 2005
Employees
8 as of 01/06/2025
Shell
No
Products and Services

Uranium exploration company backed by industry leaders and build for large-scale exploration in Canada's Athabasca Basin.

Company Facilities

Purepoint Uranium Group Inc. (TSXV: PTU) (OTCQB: PTUUF) is a focused explorer with a dynamic portfolio of advanced projects within the renowned Athabasca Basin in Canada. The most prospective projects are actively operated on behalf of partnerships with industry leaders including Cameco Corporation, Orano Canada Inc. and IsoEnergy Ltd. Additionally, the Company holds a promising VHMS project currently optioned to and strategically positioned adjacent to and on trend with Foran Corporation’s McIlvena Bay project. Through a robust and proactive exploration strategy, Purepoint is solidifying its position as a leading explorer in one of the globe’s most significant uranium districts.

OTCQB Venture Market Logo
Venture Market
The Company Profile data was verified by the issuer within the previous 6 months.
This company has certified to OTC Markets Group that it is eligible to rely on the exemption from registration under Securities and Exchange Act Rule 12g3-2(b).
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
The Company’s board of directors includes at least two Independent Directors.
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.